Use Hospira Inc. management performance concurrently with your other holdings to enhance returns of your portfolios and to back test it against optimization strategy that fits your risk preferences.
Hospira Management Effectiveness
The company has Return on Asset of 3.86 % which means that on every $1 spent on asset it made $3.86 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of (3.67) % meaning that it generated no profit with money invested by stockholders.
Hospira Profit Margins
The company has Net Profit Margin of (2.96) % which means that it does not effectively controls expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 9.37 % which entails that for every dolor of revenue it generated 0.09 of operating income.
Hospira Insiders
Michael Ball CEO, Director and Member of Science, Technology and Quality Committee
John Staley Chairman, Member of Governance and Public Policy Committee, Member of Search Committee and Member of Science, Technology and Quality Committee
Richard Davies Senior Vice President Chief Commercial Officer, MBA
Richard Hoffman Chief Accounting Officer, Corporate Vice President Controller
Hospira Inc. is one of the top stocks in number of employees category among related companies. The total workforce of Drug Delivery industry is currently estimated at about 24,221. Hospira totals roughly 15,000 in number of employees claiming about 62% of equities under Drug Delivery industry.
Chairman, Member of Governance and Public Policy Committee, Member of Search Committee and Member of Science, Technology and Quality Committee
Mr. John C. Staley is Independent NonExecutive Chairman of the Board of Hospira Inc., since January 3, 2012. Mr. Staley was a Hospira director since the company?s inception in 2004. Mr. ...
Hospira employes about 15000 people. The company is managed by 24 executives with total tenure of roughly 68 years, averanging almost 2.0 years of service per executive having 625.0 employee per reported executive.
Return on Hospira Manpower
Revenue Per Employee
268 K
Revenue Per Executive
167.5 M
Net Loss Per Employee
7.9 K
Net Loss Per Executive
5 M
Working Capital Per Employee
116.8 K
Working Capital Per Executive
73 M
Hospira Earnings Per Share
According to company disclosure Hospira Inc. has Earnings Per Share of -0.73 times. This is 168.87% lower than that of Healthcare sector, and 240.38% lower than that of Drug Delivery industry, The Earnings Per Share for all stocks is 149.32% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
